Why Is Sportradar Group AG (SRAD) Stock Down -19.53% Today?
Key Takeaways
- SRAD shares plunged approximately 19.5% after the sports data provider reported disappointing second-quarter 2026 results and lowered its full-year revenue growth outlook.
- The company swung to a net loss of roughly €4 million, driven primarily by unrealized foreign currency losses tied to U.S. dollar-denominated sports rights.
- Revenue of €378 million rose 19% year-over-year but came in below the consensus analyst forecast, rattling investor confidence.
- Full-year constant-currency revenue growth guidance was trimmed to 19%–21%, down from the prior range of 23%–25%.
- A broader backdrop of analyst downgrades and an ongoing securities class-action lawsuit have compounded selling pressure on the stock, which was already down roughly 39% year-to-date before this earnings-driven selloff.
- Traders are now watching for management's commentary on the earnings call, any further analyst revisions, and developments in the company's partnership pipeline.
Opening Summary
SRAD — Sportradar Group AG, a global sports technology company that supplies real-time data, analytics, and betting solutions to the sports wagering and media industries — cratered roughly 19.5% in Monday's trading session. As of midday, shares were changing hands near $11.70, down sharply from Friday's close of $14.54. The selloff was triggered by the company's second-quarter 2026 earnings release, which revealed a swing to a quarterly loss, a top-line miss versus Wall Street expectations, and a downward revision to full-year revenue growth guidance.
Q2 Earnings Miss: Loss, Revenue Shortfall, and FX Headwinds
Sportradar reported a comprehensive loss of approximately €4 million for the second quarter, a stark reversal from the €49 million profit booked in the same period a year earlier. The loss was driven in large part by unrealized foreign currency losses — specifically a €9 million FX headwind tied to U.S. dollar-denominated sports rights, versus a €54 million FX gain in the prior-year quarter. Severance costs linked to cost-efficiency initiatives also weighed on the bottom line.
While total revenue increased 19% year-over-year to €378 million, the figure fell short of the roughly €382 million consensus estimate. The company's Betting Technology & Solutions segment grew 21%, fueled by contributions from the IMG ARENA acquisition and new customer uptake. However, moderating growth in the U.S. market and unfavorable currency movements partially offset those gains. Sports Content, Technology & Services revenue rose just 9%, with the sports-performance sub-segment declining 13%.
On an adjusted basis, the company posted a loss of €0.01 per share, missing the consensus forecast for a €0.06 profit — an earnings surprise of approximately -117%.
Lowered Full-Year Guidance Shakes Confidence
Perhaps most damaging to investor sentiment was management's decision to trim full-year 2026 revenue growth guidance. Sportradar now expects constant-currency revenue growth of 19% to 21%, down from the prior outlook of 23% to 25%. On a reported basis, factoring in current exchange rates, revenue is projected at €1.518 billion to €1.533 billion. Adjusted EBITDA growth guidance was also tempered, now seen at 24% to 27% on a constant-currency basis.
The guidance cut signals that foreign exchange pressures and a decelerating U.S. sports betting market are creating stronger headwinds than previously anticipated. For a company already under scrutiny following a disappointing first quarter — where EPS missed estimates by over 130% — the lowered bar leaves little room for execution missteps in the second half of the year.
Broader Headwinds: Lawsuits and Analyst Pressure
Beyond the earnings release, SRAD has been navigating additional headwinds that have weighed on the stock. A securities class-action lawsuit was filed earlier this year alleging that the company made misleading statements about its compliance standards while engaging with certain gaming operators. Although management has not commented extensively on the litigation, the overhang has contributed to a cautious posture among institutional investors.
Analyst sentiment, while still skewing moderately bullish overall, has deteriorated in recent months. Jefferies downgraded the stock to Hold from Buy in April, slashing its price target from $30 to $14. Zacks Research downgraded SRAD to Strong Sell. Even bullish-leaning firms like Guggenheim have trimmed targets, lowering theirs to $28 from $30. The stock entered the session with a consensus Moderate Buy rating but with downward estimate momentum that has clearly spooked the market.
Market Context and Trading Activity
Monday's plunge in SRAD stands in stark contrast to the broader market, which was trading firmly in positive territory — the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite all advanced during the session. This divergence confirms that the move was driven exclusively by company-specific catalysts rather than macroeconomic forces. Trading volume surged well above the daily average of approximately 2 million shares, reflecting intense selling pressure as investors digested the earnings report.
On the technical front, the stock sliced through its 50-day moving average of roughly $14.82 and its 200-day moving average near $16.08. The 52-week range, spanning from $11.66 to $32.22, now places SRAD perilously close to its annual low — a level that could serve as the next key support test if selling momentum persists.
What Comes Next for SRAD
The immediate focus for investors will be management's commentary during the earnings conference call, particularly any color on the trajectory of U.S. market growth, foreign exchange hedging strategies, and margin expectations for the second half. The company's recent strategic partnerships — including multi-year deals with prediction market platforms Kalshi and Polymarket, as well as the Wimbledon data rights extension — represent genuine growth opportunities, but the market is clearly demanding evidence that these can translate into accelerating revenue and sustainable profitability.
Upcoming quarterly reports will be scrutinized for signs of stabilization in U.S. betting-related revenue and traction with new product offerings like Playradar. Risks remain tilted to the downside if currency headwinds persist, if the class-action litigation escalates, or if execution on the IMG ARENA integration disappoints. Conversely, any upside surprise in the third quarter or a favorable resolution of legal overhangs could trigger a sharp relief rally, given the stock's deeply discounted valuation relative to its 52-week highs.
Trending AI Robots
In volatile markets, traders increasingly turn to technology-driven strategies to identify opportunities and manage risk. Tickeron's Trending AI Robots page curates a selection of the platform's strongest-performing AI trading bots, drawn from hundreds of available strategies covering thousands of tickers. Only bots that have demonstrated consistent strength under current market conditions make the cut — and they span a wide range of strategies, timeframes, and performance metrics. Exploring this curated list can help traders discover data-driven approaches suited to today's shifting market landscape.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
SRAD's Stochastic Oscillator sits in oversold zone for 5 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRAD advanced for three days, in 225 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
SRAD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRAD as a result. In 69 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for SRAD turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 33 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
SRAD moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRAD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for SRAD entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. SRAD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.148) is normal, around the industry mean (51.693). P/E Ratio (219.293) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.627) is also within normal values, averaging (70.184).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement